Q&A: General Catalyst on AI and digital health funding in 2024

Holly Maloney, managing director at General Catalyst, emphasizes the need for digital health stakeholders to focus on improving care access, outcomes, cost, and workforce retention. She discusses the potential for AI to assist with the administrative burden in healthcare and drive truly personalized solutions. Maloney also anticipates continued healthy funding at early stages in 2024,…

Read More

Listen to the Latest ‘KFF Health News Minute’

Kaiser Health News is a leading nonprofit newsroom focused on health and health policy. They distribute their journalism for free and without advertising through media partners of all sizes. KHN is an editorially independent program of KFF (Kaiser Family Foundation) and you can support them by making a contribution to KFF, a non-profit charitable organization…

Read More

FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer

Pembrolizumab, also known as Keytruda, has been approved by the FDA for the treatment of stage 3-4a cervical cancer in combination with chemoradiation therapy. This marks the 40th indication for the drug, which has been used to treat 19 different types of cancer. The approval was based on a trial showing that patients receiving pembrolizumab…

Read More
error: Content is protected !!